---
title: "CRIS Connect: AI4HealthyCitiesSG: Regional Blueprint on Effective
  Interventions in Population Health"
permalink: /cris-connect-ai4healthycitiessg-regional-blueprint-on-effective-interventions-in-population-health/
date: 2025-10-13
layout: post
description: ""
image: ""
variant: tiptap
---
<p></p>
<div class="isomer-image-wrapper">
<img style="width: 100%" height="auto" width="100%" alt="" src="/images/Resources_Events/2025/CRIS_Connect_Oct_2025_v2.jpg">
</div>
<p></p>
<h4><strong>Registration</strong></h4>
<p><strong>Please register via</strong>  <strong><a href="https://for.sg/crisconnect" rel="noopener noreferrer nofollow" target="_blank"><u>https://for.sg/crisconnect</u></a></strong> 
<a href="https://for.sg/crisconnect" rel="noopener noreferrer nofollow" target="_blank"><u><br></u>
</a><a href="https://for.sg/crisconnect" rel="noopener nofollow" target="_blank">Registration</a> closes
Mon, 27 Oct 2025.</p>
<hr>
<h4><strong>About the Speakers</strong></h4>
<p><strong>Dr Matthew Arentz</strong>
<br><em>Director<br>Precision Health, Novartis Foundation</em>
</p>
<p>As the Director of Precision Health at the Novartis Foundation, Dr Matthew
Arentz leads initiatives that leverage AI and digital tools to drive advancements
in predictive and preventive population health. His work involves utilizing
data and modeling tools to improve overall health outcomes, focusing on
precision population health across cities.</p>
<p>Dr Arentz is a trained physician who specialises&nbsp; in pulmonary medicine,
infectious diseases, and global health. He has extensive experience in
health policy making, outcomes research, and modeling, working at the intersection
of technology and healthcare.</p>
<p>Dr Arentz is passionate in improving health and healthcare for everyone,
regardless of who they are and where they live.</p>
<p><strong>Prof Derek Hausenloy</strong>
<br><em>Executive Director<br>Cardiovascular Disease National Collaborative Enterprise (CADENCE)<br>Consortium for Clinical Research and Innovation, Singapore (CRIS)</em>
</p>
<p><em>Research Director and Senior Consultant<br>National Health Resarch Institute Singapore<br>National Health Centre Singapore (NHCS)</em>
</p>
<p><em>Faculty Professor<br>Cardiovascular &amp; Metabolic Disorders Signature Programme<br>Duke-NUS Medical School</em>
</p>
<p>As the Executive Director of <a href="https://www.cadence-cvd.sg" rel="noopener nofollow" target="_blank">CADENCE</a>, Prof Derek Hausenloy leads
the integration of existing research capabilities across academic and public
health institutes in order to propel Singapore to be a global leader in
cardiovascular research.</p>
<p>Prof Hausenloy is also a Research Director and Senior Consultant at the
National Heart Centre Singapore (NHCS). On top of his clinical appointment
and directorships, he holds an academic appointment at Duke-NUS Medical
School as a Professor for the Cardiovascular &amp; Metabolic Disorders
Signature Programme.</p>
<p>Prof Hausenloy is a National Medical Research Council STaR Investigator
Awardee who has been a PI for more than 40 research grants. He has authored
over 400 papers (H-index 115), and was named Highly Cited Researcher by
Clarivate Analytics (awarded to the top 0.1% of researchers worldwide)
in 2018, 2020-2025).</p>
<p>His main research focus is on discovering novel therapies for protecting
the heart against acute ischaemia/reperfusion injury and heart failure.
<br>
</p>